Cas:16357-59-8 N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline manufacturer & supplier

We serve Chemical Name:N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline CAS:16357-59-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline

Chemical Name:N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline
CAS.NO:16357-59-8
Synonyms:1-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline;2-Ethoxy-1-ethoxycarbonyl-1,2-dihydroquinoline;1(2H)-Quinolinecarboxylic acid, 2-ethoxy-, ethyl ester;Ethyl 1,2-dihydro-2-ethoxyquinoline-1-carboxylate;2-Ethoxy-1(2H)-quinolinecarboxylic Acid Ethyl Ester;EEDQ;EINECS 240-418-2;Ethyl-2-ethoxychinolin-1(2H)-carboxylat;ethyl 2-ethoxy-2H-quinoline-1-carboxylate;2-Ethoxy-1-ethoxycarbonyl-1,2-dihydroquinoline (EEDQ);ethyl 2-ethoxyquinoline-1(2H)-carboxylate;MFCD00006703;Ethyl 2-ethoxy-1(2H)-quinolinecarboxylate
Molecular Formula:C14H17NO3
Molecular Weight:247.290
HS Code:29334990

Physical and Chemical Properties:
Melting point:62-67 °C(lit.)
Boiling point:355.9±42.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.565
PSA:38.77000
Exact Mass:247.120850
LogP:2.98

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like 1-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ethyl 2-ethoxy-1(2H)-quinolinecarboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Ethoxy-1(2H)-quinolinecarboxylic Acid Ethyl Ester Use and application,EINECS 240-418-2 technical grade,usp/ep/jp grade.


Related News: Speaking to Sky News, Raab said he could not confirm the ��precise number�� of those arriving into the UK on Sunday. N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline manufacturer The two trials studied similar patient populations, Tendler said, but VMP was an old standard of care that’s not really used today in the U.S. Still, Tendler believes the two regimens may both have roles to play based on each patient’s ability to tolerate them. Whichever cocktail physicians choose, the two phase 3 studies have confirmed the benefit of Darzalex in transplant-ineligible patients, he added. N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline supplier The European Medicines Agency did not say how many shots were affected, but Reuters has reported it involves millions of doses, making it harder for J&J to meet a target of delivering 55 million to Europe by end of June. N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline vendor The European Medicines Agency did not say how many shots were affected, but Reuters has reported it involves millions of doses, making it harder for J&J to meet a target of delivering 55 million to Europe by end of June. N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline factory Rigosertib, in its intravenous formulation, is currently in Phase 3 clinical development for the treatment of higher-risk MDS.